Literature DB >> 385208

Clinical pharmacokinetics of local anaesthetics.

G T Tucker, L E Mather.   

Abstract

The introduction of the new long acting local anaesthetics, bupivacaine and etidocaine, has stimulated an expansion of interest in regional anaesthesia, particularly for obstetrical applications and pain therapy. System toxicity following injection of local anesthetics occurs albeit infrequently, and tentative correlations have been made between the onset of CNS and cardiovascular effects and circulating drug concentrations in both adults and neonates. Amongst other factors, interpretation of these relationships depends upon blood distribution and plasma binding of the agents, sampling sites and acid-base balance. The disposition kinetics and placental transfer of the amide type agents have been well characterised. In adults their clearance is almost entirely hepatic but in neonates an increase in the renal component is, in part, a reflection of the immaturity of some of the enzymes responsible for their metabolism. Ester type agents are rapidly hydrolysed by plasma pseudocholinesterase and this has led to a preference for chloroprocaine in some obstetric procedures. Major determinants of the systemic absorption of the agents after perineural administration include their physicochemical and vasoactive properties, perfusion and tissue binding at the site of injection and whether or not adrenaline has been added. In respect of blood drug concentrations achieved after various regional anaesthetic procedures, the margin of systemic safety appears to favour bupivacaine and etidocaine compared to shorter acting analogues such as lignocaine and mepivacaine. The time course of local anaesthetic remaining at the site of injection has been calculated following intravenous regional anaesthesia and peridural block. This has allowed prediction of the local and systemic accumulation of the drugs following contined dosage. Blood concentrations of local anaesthetics after perineural injection are not closely related to age, weight or pregnancy but may be influenced by diseases associated with haemodynamic changes and by other drugs given at or around the time of regional blockade.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385208     DOI: 10.2165/00003088-197904040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  162 in total

1.  Concentration of bupivacaine in arterial and venous plasma after epidural anaesthesia in man and after intramuscular administration in dog.

Authors:  P Belfrage; L Irestedt; A Berlin
Journal:  Acta Anaesthesiol Scand       Date:  1975       Impact factor: 2.105

2.  Effects of pH on protein binding of lidocaine.

Authors:  R G Burney; C A DiFazio; J A Foster
Journal:  Anesth Analg       Date:  1978 Jul-Aug       Impact factor: 5.108

3.  Placental transfer of lidocaine: effects of fetal acidosis.

Authors:  D Biehl; S M Shnider; G Levinson; K Callender
Journal:  Anesthesiology       Date:  1978-06       Impact factor: 7.892

4.  The convulsant potency of lidocaine and its N-dealkylated metabolites.

Authors:  J Blumer; J M Strong; A J Atkinson
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

5.  The determination of lidocaine and prilocaine in whole blood by gas chromatography.

Authors:  J B Keenaghan
Journal:  Anesthesiology       Date:  1968 Jan-Feb       Impact factor: 7.892

6.  Dynamics of local-anesthetic compounds in regional anesthesia.

Authors:  P P Raj; R Rosenblatt; J Miller; R L Katz; E Carden
Journal:  Anesth Analg       Date:  1977 Jan-Feb       Impact factor: 5.108

7.  Bupivacaine and lignocaine induced seizures in rhesus monkeys.

Authors:  E S Munson; R W Martucci; I H Wagman
Journal:  Br J Anaesth       Date:  1972-10       Impact factor: 9.166

8.  Dosage of lignocaine in epidural block in relation to toxicity.

Authors:  D P Braid; D B Scott
Journal:  Br J Anaesth       Date:  1966-08       Impact factor: 9.166

9.  Diazepam in the prophylaxis of lignocaine seizures.

Authors:  B Ausinsch; M H Malagodi; E S Munson
Journal:  Br J Anaesth       Date:  1976-04       Impact factor: 9.166

Review 10.  Clinical pharmacokinetics of lignocaine.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

View more
  45 in total

Review 1.  [Toxicology of local anesthetics. Clinical, therapeutic and pathological mechanisms].

Authors:  W Zink; B M Graf
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  The effect of age on the systemic absorption, disposition and pharmacodynamics of bupivacaine after epidural administration.

Authors:  B T Veering; A G Burm; A A Vletter; R P van den Heuvel; W Onkenhout; J Spierdijk
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 4.  Local anesthetics.

Authors:  J A Yagiela
Journal:  Anesth Prog       Date:  1991 Jul-Oct

5.  Comparison of the effects and disposition kinetics of articaine and lidocaine in 20 patients undergoing intravenous regional anaesthesia during day case surgery.

Authors:  M A Simon; T B Vree; M J Gielen; L H Booij
Journal:  Pharm World Sci       Date:  1998-04

Review 6.  Adverse effects and drug interactions associated with local and regional anaesthesia.

Authors:  M Naguib; M M Magboul; A H Samarkandi; M Attia
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

7.  The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.

Authors:  N D Bax; G T Tucker; M S Lennard; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

8.  Bupivacaine kinetics during hyperthermia in rats.

Authors:  B Bruguerolle; X Roucoules; L Attolini; A M Lorec
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

Review 9.  Obstetric analgesia. Clinical pharmacokinetic considerations.

Authors:  J Kanto
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics of epidural and spinal anaesthesia.

Authors:  A G Burm
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.